Olink announces receipt of CMA clearance for proposed acquisition by Thermo Fisher
Shares and American Depositary Shares of Olink for $26.00 per Share
Shares and American Depositary Shares of Olink for $26.00 per Share
Achievement of This Major Milestone Further Simplifies and Strengthens the Company and Positions Viatris to Achieve its Key Priorities and Accelerate Future Growth
NCIL was listed at Rs. 171 at an upper circuit premium of 90% over the fixed price band of Rs. 90
Dabur's consolidated revenue is expected to register mid to high single digit growth during Q1 FY25
Aim of the collaboration is to develop mRNA platform technology, scale up and troubleshoot challenges in mRNA process optimization
Alembic Pharmaceuticals receives 11 USFDA product approval during Q1 FY2025
Yann d’Hervé takes over responsibility for the Health Care business at Evonik, effective July 1
The expiry date of almost all strips is rubber stamped vanish in a matter of 3 to 4 months, making the remaining tablets waste for subsequent use before expire date
Submission based on positive SUPERNOVA Phase III trial data which demonstrated a statistically significant reduction in the incidence of COVID?19 in an immunocompromised patient population
Ibara will drive AI-powered clinical research innovation
Subscribe To Our Newsletter & Stay Updated